FY2024 EPS Estimate for Cronos Group Increased by Analyst

Cronos Group Inc. (NASDAQ:CRON - Free Report) - Analysts at Roth Capital upped their FY2024 earnings estimates for shares of Cronos Group in a report issued on Wednesday, November 13th. Roth Capital analyst W. Kirk now expects that the company will post earnings per share of ($0.06) for the year, up from their previous forecast of ($0.08). The consensus estimate for Cronos Group's current full-year earnings is ($0.05) per share.

Cronos Group Stock Down 2.9 %

NASDAQ CRON traded down $0.06 during midday trading on Friday, hitting $2.01. The company had a trading volume of 1,249,013 shares, compared to its average volume of 1,932,515. The stock has a market cap of $768.42 million, a price-to-earnings ratio of -15.46 and a beta of 0.98. The firm has a fifty day simple moving average of $2.17 and a two-hundred day simple moving average of $2.35. Cronos Group has a fifty-two week low of $1.85 and a fifty-two week high of $3.14.

Institutional Trading of Cronos Group

Several institutional investors have recently made changes to their positions in CRON. Tidal Investments LLC acquired a new stake in shares of Cronos Group during the 1st quarter valued at about $17,217,000. Mackenzie Financial Corp acquired a new stake in shares of Cronos Group during the 2nd quarter valued at about $3,237,000. Dimensional Fund Advisors LP boosted its position in shares of Cronos Group by 7.9% during the 2nd quarter. Dimensional Fund Advisors LP now owns 2,631,783 shares of the company's stock valued at $6,132,000 after acquiring an additional 192,469 shares in the last quarter. Intact Investment Management Inc. boosted its position in shares of Cronos Group by 89.1% during the 3rd quarter. Intact Investment Management Inc. now owns 377,890 shares of the company's stock valued at $836,000 after acquiring an additional 178,100 shares in the last quarter. Finally, Renaissance Technologies LLC boosted its position in shares of Cronos Group by 37.9% during the 2nd quarter. Renaissance Technologies LLC now owns 464,949 shares of the company's stock valued at $1,083,000 after acquiring an additional 127,753 shares in the last quarter. 8.71% of the stock is currently owned by institutional investors and hedge funds.

Cronos Group Company Profile

Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.